Patients with LCC were prevalently treated with an anti-EGFR agent as compared to those with RCC (71.95 vs 64.8%, respectively), although the difference was not statistically significant (p= 0.179). Here, EGFR is linked to leukoencephalopathy with calcifications and cysts.